Anti-GBM disease with a mild relapsing course and low levels of anti-GBM autoantibodies

Clinical Kidney Journal

Volumn 5, Issue 6, 2012, Pages 549-551

  Segelmark, Mårten ^a,b,c   Dahlberg, Per ^d   Wieslander, Jörgen ^e  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Operations and Specialty Surgery Center   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d NAL Hospital   (Sweden)

^e EuroDiagnostica AB   (Sweden)

Author keywords

anti GBM; glomerulonephritis; Goodpasture's disease; relapses

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; PROTEIN A;

AGED; APHERESIS; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FACIAL NERVE PARALYSIS; FEMALE; FOCAL GLOMERULONEPHRITIS; FOLLOW UP; GLOMERULONEPHRITIS; HEMATURIA; HOSPITAL DISCHARGE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; MYALGIA; PRIORITY JOURNAL; PROTEINURIA;

EID: 84870573326     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfs098     Document Type: Article

References (10)

1. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. New Engl J Med 2003; 348(25): 2543-2556 (Pubitemid 36706542)
2. Yang R, Hellmark T, Zhao J et al. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant 2009; 24(6): 1838-1844
3. Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of anti-glomerular- basement-membrane antibodies. Nephron Clin Pract 2003; 94(3): c59-c68
4. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001; 134(11): 1033-1042 (Pubitemid 32488657)
5. Levy JB, Lachmann RH, Pusey CD. Recurrent Goodpasture's disease. Am J Kidney Dis 1996; 27(4): 573-578 (Pubitemid 26106606)
6. Trpkov K, Abdulkareem F, Jim K, Solez K. Recurrence of anti- GBM antibody disease twelve years after transplantation associated with de novo IgA nephropathy. Clin Nephrol 1998; 49(2): 124-128 (Pubitemid 28073506)
7. Fonck C, Loute G, Cosyns JP, Pirson Y. Recurrent fulminant anti-glomerular basement membrane nephritis at a 7-year interval. Am J Kidney Dis 1998; 32(2): 323-327
8. Yang R, Hellmark T, Zhao J et al. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with Goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 2007; 18(4): 1338-1343 (Pubitemid 46536921)
9. Verburgh CA, Bruijn JA, Daha MR, van Es LA. Sequential development of anti-GBM nephritis and ANCA-associated Pauci-immune glomerulonephritis. Am J Kidney Dis 1999; 34 (2): 344-348 (Pubitemid 29362103)
10. Serratrice J, Chiche L, Dussol B et al. Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis 2004; 43(3): e26-e30